Literature DB >> 21979826

Revolutionary change in rheumatoid arthritis management with biological therapy.

Tsutomu Takeuchi1.   

Abstract

Biological agents targeting a specific molecule have extraordinarily fine specificity and powerful functional capabilities. By the introduction of biological therapy, management of rheumatoid arthritis has undergone a revolution and a paradigm shift. In this review, I will summarize the role in the pathogenesis of rheumatoid arthritis of the molecules targeted by biological agents. Providing evidence obtained in clinical trials and investigator-initiated clinical studies in Japan, the effectiveness and safety of biological therapy in rheumatoid arthritis are discussed. Finally, studies aiming at a personalized strategy with biological agents are listed and the future perspectives toward tailor-made medicine in the field of rheumatology are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979826     DOI: 10.2302/kjm.60.75

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  11 in total

1.  Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.

Authors:  Tara L Aghaloo; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2016-07-30       Impact factor: 1.895

2.  UP446, analgesic and anti-inflammatory botanical composition.

Authors:  Mesfin Yimam; Lidia Brownell; Mandee Pantier; Qi Jia
Journal:  Pharmacognosy Res       Date:  2013-07

3.  Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling.

Authors:  Sho Mokuda; Masamoto Kanno; Kiyoshi Takasugi; Chikara Okumura; Yuki Ito; Junya Masumoto
Journal:  SAGE Open Med Case Rep       Date:  2014-01-08

Review 4.  Long-term treatment of rheumatoid arthritis with adalimumab.

Authors:  Giuseppe Murdaca; Francesca Spanò; Francesco Puppo
Journal:  Open Access Rheumatol       Date:  2013-05-07

Review 5.  The role of interleukin-1 in general pathology.

Authors:  Naoe Kaneko; Mie Kurata; Toshihiro Yamamoto; Shinnosuke Morikawa; Junya Masumoto
Journal:  Inflamm Regen       Date:  2019-06-06

6.  Analgesic and Anti-Inflammatory Activities of the Ethanolic Extract of Artemisia morrisonensis Hayata in Mice.

Authors:  Shen-Chieh Chou; Yung-Jia Chiu; Chao-Jung Chen; Ying-Chih Lin; Chung-Hao Wu; Chien-Ti Chao; Ching-Wen Chang; Wen-Huang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-29       Impact factor: 2.629

7.  Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.

Authors:  Tsutomu Takeuchi; Hisashi Yamanaka; Naoki Ishiguro; Nobuyuki Miyasaka; Masaya Mukai; Tsukasa Matsubara; Shoji Uchida; Hideto Akama; Hartmut Kupper; Vipin Arora; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2013-01-11       Impact factor: 19.103

8.  Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).

Authors:  Yuko Kaneko; Tatsuya Atsumi; Yoshiya Tanaka; Masayuki Inoo; Hitomi Kobayashi-Haraoka; Koichi Amano; Masayuki Miyata; Yohko Murakawa; Hidekata Yasuoka; Shintaro Hirata; Hayato Nagasawa; Eiichi Tanaka; Nobuyuki Miyasaka; Hisashi Yamanaka; Kazuhiko Yamamoto; Tsutomu Takeuchi
Journal:  Ann Rheum Dis       Date:  2016-01-05       Impact factor: 19.103

Review 9.  Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease.

Authors:  Tsutomu Takeuchi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

10.  Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials.

Authors:  Mingliang Qiu; Zhongbo Xu; Wenjuan Gao; Meizhen Xiong; Xianhua Wen; Weina Zhu; Xu Zhou; Minfeng Yu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.